Comparison of human isogeneic Wharton’s jelly MSCs and iPSC-derived MSCs reveals differentiation-dependent metabolic responses to IFNG stimulation

[1]  D. Strunk,et al.  Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  D. Ilic,et al.  Induced pluripotent stem cell line from an atopic dermatitis patient heterozygous for c.2282del4 mutation in filaggrin: KCLi001-A , 2018, Stem cell research.

[3]  L. Lartigue,et al.  Metabolic Stress in the Immune Function of T Cells, Macrophages and Dendritic Cells , 2018, Cells.

[4]  P. Gressens,et al.  Embryonic Stem Cell‐Derived Mesenchymal Stem Cells (MSCs) Have a Superior Neuroprotective Capacity Over Fetal MSCs in the Hypoxic‐Ischemic Mouse Brain , 2018, Stem cells translational medicine.

[5]  D. Ilic,et al.  Effects of maternal obesity on Wharton’s Jelly mesenchymal stromal cells , 2017, Scientific Reports.

[6]  Michael Raghunath,et al.  Concise Review: Multifaceted Characterization of Human Mesenchymal Stem Cells for Use in Regenerative Medicine , 2017, Stem cells translational medicine.

[7]  E KlontzasMichail,et al.  Metabolomics Analysis of the Osteogenic Differentiation of Umbilical Cord Blood Mesenchymal Stem Cells Reveals Differential Sensitivity to Osteogenic Agents , 2017 .

[8]  Athanasios Mantalaris,et al.  Metabolomics Analysis of the Osteogenic Differentiation of Umbilical Cord Blood Mesenchymal Stem Cells Reveals Differential Sensitivity to Osteogenic Agents , 2017, Stem cells and development.

[9]  Davis J. McCarthy,et al.  Common genetic variation drives molecular heterogeneity in human iPSCs , 2017, Nature.

[10]  Gaurav Pandey,et al.  Analysis of Transcriptional Variability in a Large Human iPSC Library Reveals Genetic and Non-genetic Determinants of Heterogeneity. , 2017, Cell stem cell.

[11]  Bing Ren,et al.  Large-Scale Profiling Reveals the Influence of Genetic Variation on Gene Expression in Human Induced Pluripotent Stem Cells. , 2017, Cell stem cell.

[12]  A. Mantalaris,et al.  Human embryonic and induced pluripotent stem cells maintain phenotype but alter their metabolism after exposure to ROCK inhibitor , 2017, Scientific Reports.

[13]  Zhenqiu Liu,et al.  Human Induced Pluripotent Stem Cells Differentiate Into Functional Mesenchymal Stem Cells and Repair Bone Defects , 2016, Stem cells translational medicine.

[14]  B. Hinz,et al.  Faculty Opinions recommendation of The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. , 2016 .

[15]  D. Schwahn,et al.  Mesenchymoangioblast-derived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlimb ischemic injury in mice. , 2016, Cytotherapy.

[16]  Ivan Martin,et al.  International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. , 2016, Cytotherapy.

[17]  D. Ilic,et al.  Sendai Virus-Based Reprogramming of Mesenchymal Stromal/Stem Cells from Umbilical Cord Wharton's Jelly into Induced Pluripotent Stem Cells. , 2016, Methods in molecular biology.

[18]  M. E. Scassa,et al.  A therapy-grade protocol for differentiation of pluripotent stem cells into mesenchymal stem cells using platelet lysate as supplement , 2015, Stem Cell Research & Therapy.

[19]  Linnan Zhu,et al.  Cellular Metabolism and Macrophage Functional Polarization , 2015, International reviews of immunology.

[20]  Eoin P. McNeill,et al.  MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs , 2014, Proceedings of the National Academy of Sciences.

[21]  Dheraj K Taheem,et al.  Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation. , 2014, Regenerative medicine.

[22]  Wei Cao,et al.  Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications , 2014, Nature Immunology.

[23]  Wolfgang Wagner,et al.  Epigenetic Rejuvenation of Mesenchymal Stromal Cells Derived from Induced Pluripotent Stem Cells , 2014, Stem cell reports.

[24]  Nicholas A. Kouris,et al.  Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties. , 2014, Stem cells and development.

[25]  Anna Sarnowska,et al.  Low oxygen atmosphere facilitates proliferation and maintains undifferentiated state of umbilical cord mesenchymal stem cells in an hypoxia inducible factor-dependent manner. , 2014, Cytotherapy.

[26]  ViswanathanSowmya,et al.  Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation. , 2014 .

[27]  R. Vaughan,et al.  3D In Vitro Model of a Functional Epidermal Permeability Barrier from Human Embryonic Stem Cells and Induced Pluripotent Stem Cells , 2014, Stem cell reports.

[28]  Yufang Shi,et al.  Immunobiology of mesenchymal stem cells , 2013, Cell Death and Differentiation.

[29]  Glyn Stacey,et al.  Soliciting Strategies for Developing Cell-Based Reference Materials to Advance Mesenchymal Stromal Cell Research and Clinical Translation , 2014 .

[30]  John N Weinstein,et al.  Measurement of DNA concentration as a normalization strategy for metabolomic data from adherent cell lines. , 2013, Analytical chemistry.

[31]  M. Klapa,et al.  Metabolic profiling reveals that time related physiological changes in mammalian cell perfusion cultures are bioreactor scale independent. , 2013, Metabolic engineering.

[32]  F. Farina,et al.  Umbilical cord revisited: from Wharton's jelly myofibroblasts to mesenchymal stem cells. , 2013, Histology and histopathology.

[33]  R. Derynck,et al.  TGF-β family signaling in stem cells. , 2013, Biochimica et biophysica acta.

[34]  H. Drissi,et al.  Efficient differentiation of human iPSC‐derived mesenchymal stem cells to chondroprogenitor cells , 2013, Journal of cellular biochemistry.

[35]  H. Hennies,et al.  Induced pluripotent mesenchymal stromal cell clones retain donor-derived differences in DNA methylation profiles. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  Xu Cao,et al.  The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine , 2013, Nature Medicine.

[37]  D. Ilic,et al.  Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product–free environment , 2012, Nature Protocols.

[38]  J. Bolleyn,et al.  Mesoderm-derived stem cells: the link between the transcriptome and their differentiation potential. , 2012, Stem cells and development.

[39]  L. Deng,et al.  Umbilical cord versus bone marrow-derived mesenchymal stromal cells. , 2012, Stem cells and development.

[40]  M. Vemuri,et al.  Defined xenogeneic-free and hypoxic environment provides superior conditions for long-term expansion of human adipose-derived stem cells. , 2012, Tissue engineering. Part C, Methods.

[41]  M. Weiss,et al.  Evaluating the Impact of Oxygen Concentration and Plating Density on Human Wharton's Jelly-Derived Mesenchymal Stromal Cells , 2011 .

[42]  F. Dazzi,et al.  The immunomodulatory properties of mesenchymal stem cells , 2011, Seminars in Immunopathology.

[43]  Jerome Ritz,et al.  The elusive nature and function of mesenchymal stem cells , 2011, Nature Reviews Molecular Cell Biology.

[44]  R. Stewart,et al.  A mesoderm-derived precursor for mesenchymal stem and endothelial cells. , 2010, Cell stem cell.

[45]  Usha Nekanti,et al.  Increased Proliferation and Analysis of Differential Gene Expression in Human Wharton's Jelly-derived Mesenchymal Stromal Cells under Hypoxia , 2010, International journal of biological sciences.

[46]  A. Lavrentieva,et al.  Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells , 2010, Cell Communication and Signaling.

[47]  H. Kalbacher,et al.  The mesenchymal stem cell antigen MSCA-1 is identical to tissue non-specific alkaline phosphatase. , 2010, Stem cells and development.

[48]  Pernilla Eliasson,et al.  The hematopoietic stem cell niche: Low in oxygen but a nice place to be , 2010, Journal of cellular physiology.

[49]  L. Kanz,et al.  Phenotypic Characterization of Distinct Human Bone Marrow–Derived MSC Subsets , 2009, Annals of the New York Academy of Sciences.

[50]  P. Eriksson,et al.  Human embryonic stem cell-derived mesenchymal progenitors--potential in regenerative medicine. , 2009, Stem cell research.

[51]  Francesco Dazzi,et al.  Mesenchymal stem cells: the fibroblasts’ new clothes? , 2009, Haematologica.

[52]  S. Stice,et al.  Human embryonic stem cell-derived mesoderm-like epithelium transitions to mesenchymal progenitor cells. , 2009, Tissue engineering. Part A.

[53]  N. Reiner.  Macrophages and Dendritic Cells , 2009, Methods in Molecular Biology™.

[54]  M. Klapa,et al.  Standardizing GC-MS metabolomics. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[55]  A. Zannettino,et al.  A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells. , 2007, Stem cells and development.

[56]  M. Haniffa,et al.  Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells1 , 2007, The Journal of Immunology.

[57]  M. Salto‐Tellez,et al.  Derivation of Clinically Compliant MSCs from CD105+, CD24− Differentiated Human ESCs , 2007, Stem cells.

[58]  M. Klapa,et al.  Data correction strategy for metabolomics analysis using gas chromatography-mass spectrometry. , 2007, Metabolic engineering.

[59]  Sergio Romagnani,et al.  Role for Interferon‐γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells , 2006 .

[60]  Sergio Romagnani,et al.  Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. , 2006, Stem cells.

[61]  D. Vestal.  The guanylate-binding proteins (GBPs): proinflammatory cytokine-induced members of the dynamin superfamily with unique GTPase activity. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[62]  N. Socci,et al.  Derivation of Multipotent Mesenchymal Precursors from Human Embryonic Stem Cells , 2005, PLoS medicine.

[63]  Gregory J. Brewer,et al.  Survival at low and growth of hippocampal neurons in defined medium density : advantages of a sandwich culture technique or low oxygen , 2002 .

[64]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[65]  J. Flier,et al.  Genomic organization, sequence and transcriptional regulation of the human CXCL 11(1) gene. , 1999, Biochimica et biophysica acta.

[66]  G. Brewer,et al.  Optimized survival of hippocampal neurons in B27‐supplemented neurobasal™, a new serum‐free medium combination , 1993, Journal of neuroscience research.

[67]  Gregory J. Brewer,et al.  Survival and growth of hippocampal neurons in defined medium at low density: advantages of a sandwich culture technique or low oxygen , 1989, Brain Research.